Natasha Campbell

Clinical Trials Manager with a background in neurology and neuroscience. Our team runs psychedelic-assisted therapy studies (+ other drug and device studies) near Vancouver, British Columbia. Ongoing studies: Clairvoyant Therapeutics (psilocybin in Alcohol Use Disorder); COMPASS Pathways COMP006 (psilocybin in treatment-resistant Depression)